Delay in administration of CDDP until completion of AGM-1470 treatment enhances antimetastatic and antitumor effects

Clinical and Experimental Metastasis

Volumn 17, Issue 1, 1999, Pages 15-18

  Morishita, Toru ^a   Miyauchi, Yoshizumi ^a   Mii, Yoshio ^a   Miura, Shuichi ^a   Honoki, Kanya ^a   Aoki, Makoto ^a   Kido, Akira ^a   Yoshimoto, Masatoshi ^a   Tamai, Susumu ^a   Tsutsumi, Masahiro ^a   Konishi, Yoichi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

AGM 1470 (TNP 470); CDDP; Combination therapy; Metastasis; Rat osteosarcoma

Indexed keywords

CISPLATIN; FUMAGILLOL CHLOROACETYLCARBAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFICACY; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; MALE; METASTASIS INHIBITION; NONHUMAN; OSMOTIC PUMP; OSTEOSARCOMA; RAT; SUBCUTANEOUS TISSUE TUMOR;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CYCLOHEXANES; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; MALE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OSTEOSARCOMA; RATS; RATS, INBRED F344; SESQUITERPENES;

EID: 0033055383     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ingber D, Fujita T, Kishimoto S et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 1990; 348: 555-7.
2. Yamaoka M, Yamamoto T, Masaki T et al. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Res 1993; 53: 4262-7.
3. Yamaoka M, Yamamoto T, Ikeyama S et al. Angiogenesis inhibitor TNP470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res 1993; 53: 5233-6.
4. Takamiya Y, Friedlander, RM, Brem H et al. Inhibition of angiogenesis and growth of human nervesheath tumors by AGM-1470. J Neurosurg 1993; 78: 470-6.
5. Wilson JT, Penar PL. The effect of AGM-1470 in an improved intracranial 9L gliosarcoma rat model. Neurol Res 1994; 16: 121-4.
6. Morishita T, Mii Y, Miyauchi Y et al. Efficacy of the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (AGM-1470) on osteosarcoma growth and lung metastasis in rats. Jpn J Clin Oncol 1995; 25: 25-31.
7. Mori S, Ueda T, Kuratsu S et al. Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine oesteosarcoma. Int J Cancer 1995; 61: 148-52.
8. Kusaka M, Sudo K, Fujita T et al. Potent anti-angiogeneic action of AGM-1470: comparison to the fumagillol prent. Biochem Biophys Res Commun 1991; 174: 1070-6.
9. Kato, T, Sato K, Kakinuma H, Matsuda Y. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice. Cancer Res 1994; 54: 5143-7.
10. Nishimura Y, Murata K, Hiraoka M. Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia. Br J Cancer 1996; 73: 270-4.
11. Teicher BA, Sotomayor EA, Huang ZD. Antiangiogeneic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 1992; 52: 6702-4.
12. Devineni D, Klein-Szanto A, Gallo JM. Uptake of temozolomide in a rat model in the presence and absence of the angiogenesis inhibitor TNP-470. Cancer Res 1996; 56: 1983-7.
13. Mii Y, Tsutsumi M, Shiraiwa K et al. Transplantable osteosarcoma with high lung metastatic potential in Fischer344 rats. Jpn J Cancer Res 1988; 79: 589-92.
14. Honoki K, Tsutsumi M, Miyauchi Y et al. Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcoma. Cancer Res 1993; 53: 5038-42.
15. Jain RK. Delivery of novel therapeutic agents in tumor: physiological barriers and strategies. J Natl Cancer Inst 1989; 81: 570-6.
16. Teicher BA, Dupuis NP, Robinson MF et al. Antiangiogeneic treatment (TNP-470/Minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma. Oncol Res 1995; 7: 237-43.
17. Kusaka M, Sudo K, Matsunami E et al. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP470 (AGM-1470). Br J Cancer 1994; 69: 212-6.
18. Placidi L, Cretton-Scott E, Geordes de S et al. Disposition and metabolism of the angiogenic moderator O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) in human hepatocytes and tissue microsomes. Cancer Res 1995; 55: 3036-42.
19. Nishimura Y, Hiraoka M, Jo S et al. Microangiographic and histologic analysis of hyperthermia on murine vasculature. Int J Radiat Oncol Biol Phys 1988; 15: 411-20.
20. Folkman J. Tumor angiogenesis factor. Cancer Res 1974; 34: 2109-13.
21. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985; 43: 175-203.
22. Krotolica A, Ludlow JW. Hypoxia arrests ovarian carcinoma cell cycle progression, but invasion is unaffected. Cancer Res 1996; 56: 1168-73.
23. Schwickert G, Walenta S, Sundfor K et al. Correlation of high lactate in human cervical cancer with incidence of metastasis. Cancer Res 1995; 55: 4757-9.
24. Holmgren L, O'Reilly SM, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1995; 1: 149-53.